Purpose In patients with urothelial carcinoma CIS (carcinoma in situ) generally has a poor
prognosis. However, to our knowledge the outcomes of pure/primary CIS and the behavior …

Wong et al 1 report one of the largest cohorts of patients with upper tract urothelial
carcinoma (UTUC) investigating the prognostic value of concomitant carcinoma in situ (CIS) …

Purpose The purpose of this study is to assess the association of concomitant carcinoma in
situ (CIS) with disease recurrence and cancer-related death in a multi-institutional series of …

OBJECTIVES: Transitional cell carcinoma in situ (CIS) of the upper urinary tract is a
relatively rare disease, and treatment guidelines remain to be defined. In this study, we …

OBJECTIVES: To evaluate the effect of a history of bladder carcinoma in situ (CIS) on
relapse and survival after surgical management of metachronous upper tract urothelial …

OBJECTIVE: Carcinoma in situ (CIS) is associated with increased risk of progression when
found with high-grade non-muscle-invasive bladder cancer, yet its impact is less clear in the …

Simple Summary Although upper tract urothelial carcinoma (UTUC) is a relatively rare
malignancy in Western countries, recurrence and distant metastasis are common even after …

To evaluate the impact of urothelial carcinoma with divergent differentiation (UCDD) on the
prognosis of patients for primary upper urinary tract urothelial carcinoma (UTUC) with pN0/x …

Study Type–Diagnosis (validating cohort) Level of Evidence 1b OBJECTIVE To identify
prognostic risk factors for the development of subsequent bladder recurrence in patients …

Purpose Some excised specimens of upper tract urothelial carcinoma (UTUC) are
concomitant carcinoma in situ (CIS). However, whether concomitant CIS affects the …